35
FibroBiologics closes $1.2M raise under Regulation D exemption 6(b)
Company raise · Closed · Offering $1.2M · Sold $1.2M · HOUSTON, TX · filed 2026-10-13
35
FibroBiologics, Inc. raises $500K under Reg D
Company raise · Closed · HOUSTON, TX · Form D filed 2026-09-16
Why now — by persona
Relevant to: Executive & technical recruiting, B2B software & services sales, Commercial banking / treasury, D&O and management-liability insurance, Outsourced accounting / CFO. Lead card pending.
People on the filing
| Kathleen H. Rubins | Director |
| Hamid A. Khoja | Chief Scientific Officer |
| Robert C. Hoffman | Director |
| Ruben A. Garcia | General Counsel |
| Jason D. Davis | Chief Financial Officer |
| Leigh H. Steinberg | Director |
| Pete O'Heeron | Chief Executive Officer |
| Victoria C. Niklas | Director |
| Richard C. Cilento | Director |
Signed by Ruben A. Garcia, General Counsel.
Filing contact
The issuer's phone number and address from the filing are shown to subscribers. See plans, or read it on EDGAR.
Other filings by this issuer
45
FibroBiologics, Inc. raises $3M under Reg D
Company raise · Closed · Offering $3M · Sold $3M · HOUSTON, TX · filed 2026-06-29
Placement agent engaged
40
FibroBiologics, Inc. raises $1.7M under Reg D
Company raise · Closed · Offering $1.7M · Sold $1.7M · HOUSTON, TX · filed 2025-12-16
Placement agent engaged
45
FibroBiologics, Inc. raises $1.5M under Reg D
Company raise · Closed · Offering $1.5M · Sold $1.5M · HOUSTON, TX · filed 2025-12-03
Placement agent engaged
45
FibroBiologics, Inc. raises $4M under Reg D
Company raise · Closed · Offering $4M · Sold $4M · HOUSTON, TX · filed 2025-12-03